DADC
NVO

D.A. Davidson & Co’s Novo Nordisk NVO Stock Holding History

D.A. Davidson & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$710 – 1585
2025
Q3 		$710 Hold
1
– – ﹤0.01% 1528
2025
Q2 		$1.53K Hold
1
– – ﹤0.01% 1439
2025
Q1 		$1.68K Hold
1
– – ﹤0.01% 1399
2024
Q4 		$2.77K Buy
+1
New +$108 ﹤0.01% 1413

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

D.A. Davidson & Co's NVO Position: Q2 2026 in Review

D.A. Davidson & Co increased its Novo Nordisk (NVO) stake by 2.9% in Q2 2026, buying an estimated $67.7K and bringing the position to 56,812 shares worth $2.72M. The position accounts for 0.02% of the portfolio, ranked #637.

D.A. Davidson & Co first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.67M in Q1 2014. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • D.A. Davidson & Co held 56,812 shares of Novo Nordisk worth $2.72M as of Q2 2026.
  • D.A. Davidson & Co bought 1,576 Novo Nordisk shares in Q2 2026, an estimated $67.7K.
  • Novo Nordisk made up 0.02% of D.A. Davidson & Co's portfolio in Q2 2026, its #637 holding.
  • D.A. Davidson & Co first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • D.A. Davidson & Co's Novo Nordisk position peaked at $7.67M in Q1 2014.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.